EPAS Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of EPAS Antibodies for advanced research in molecular biology. EPAS Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EPAS, also known as HIF-2α, plays a critical role in the cellular response to hypoxia and regulates genes that control angiogenesis, erythropoiesis, and metabolism. The significance of EPAS in cancer biology and other diseases makes it a key target for therapeutic intervention and biomarker discovery. Understanding EPAS function is essential for elucidating the mechanisms of oxygen homeostasis and the pathophysiology of various conditions. Research into EPAS signaling pathways continues to reveal new insights about cellular adaptation to hypoxic conditions. Investigating EPAS expression patterns helps identify potential therapeutic targets in cancer treatment. The role of EPAS in stem cell maintenance and differentiation opens new avenues for regenerative medicine research. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of EPAS biology and its impact on human health.